Loading clinical trials...

Pilot Study in Patients With Symptomatic Steroid-Naive Asthma | Clinical Trials | Clareo Health

COMPLETEDPHASE2

Pilot Study in Patients With Symptomatic Steroid-Naive Asthma

A Phase I/II, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Pilot Study of SB 240683 in Patients With Symptomatic Steroid-Naive Asthma

NCT00024544•Facet Biotech

View on ClinicalTrials.gov

Summary

The purpose of the study is to evaluate an investigational medication to treat chronic asthma. The research is being conducted at 20 clinical research sites in the US and is open to both men and women ages 18 to 70 years. Participants in the study will have a number of visits to a research site over an 8-month period. All study-related care and medication is provided to qualified participants at no cost. This includes all visits, examinations and laboratory work.

Eligibility

Age

18 - 70 years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•At least a 6-month history of asthma
•No use of inhaled, oral or injectable steroids for at least 1 month prior to enrollment

Exclusion Criteria

•Patients with \> 10 pack years of smoking history or smoking within 12 months of study enrollment
•No significant disease other than asthma

Locations (18)

Allergy Research Foundation

Los Angeles, California, United States

Southern California Research

Mission Viejo, California, United States

Clinical Trials of Orange Cnty., Inc.

Orange, California, United States

Allergy Associates Medical Group, Inc.

San Diego, California, United States

Allergy and Asthma Associates Santa Clara Valley Research Center

San Jose, California, United States

Bensch Research Associates

Stockton, California, United States

National Jewish Medical and Research Center

Denver, Colorado, United States

ICSL Clinical Studies

Normal, Illinois, United States

Respiratory Therapy and Pulmonary Clinical Research Brigham & Women's Hospital

Boston, Massachusetts, United States

New England Clinical Studies

North Dartmouth, Massachusetts, United States

Key Dates

Start Date

August 1, 2001

Primary Completion Date

February 1, 2003

Completion Date

February 1, 2003

Last Updated

March 7, 2012

Enrollment

120

Estimated participants

Conditions

Asthma

Interventions

anti-IL-4 monoclonal antibody (pascolizumab)

DRUG

NHALES (Natural History of Asthma With Longitudinal Environmental Sampling)

NCT02327897

Asthma

View study

RECRUITINGNA

Blood Eosinophil Guided Versus Usual Care In The Management Of Mild To Moderate Asthma at Primary Care (BEAM)

NCT07486401

Asthma ExacerbationsBiomarkers / Blood+1 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 7, 2012Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Pilot Study in Patients With Symptomatic Steroid-Naive Asthma

Inclusion Criteria

Exclusion Criteria

NHALES (Natural History of Asthma With Longitudinal Environmental Sampling)

Blood Eosinophil Guided Versus Usual Care In The Management Of Mild To Moderate Asthma at Primary Care (BEAM)

A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma

Relationship of Airway Microbiota, Endotype and Phenotype in Adult Asthma

To Assess the Management of Patients on Global Initiative of Asthma (GINA) Step 4 and 5 Treatment in Hong Kong

A Study to Investigate Efficacy and Safety of PT027 Compared With PT007 in Symptomatic Chinese Adults With Asthma